UnitedHealth Group: A Promising Investment Prospect for 2026?
**UnitedHealth Group: A Promising Investment Prospect for 2026?** Key Takeaways: UBS reaffirms a buy rating on UnitedHealth Group (UNH) after a meeting with the company’s management. The company’s management confirms 65% EPS seasonality split for the first half and 35% for the second half of 2026. Optum Insight and OptumRx, two of UnitedHealth’s divisions, are … Read more